Literature DB >> 16198649

Ethnic differences in statin disposition.

Rommel G Tirona1.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16198649     DOI： 10.1016/j.clpt.2005.07.006

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  8 in total

Review 1.  Influence of drug transporter polymorphisms on pravastatin pharmacokinetics in humans.

Authors:  Kari T Kivistö; Mikko Niemi
Journal:  Pharm Res       Date:  2006-12-20       Impact factor: 4.200

2.  Impact of ABCG2 and SLCO1B1 polymorphisms on pharmacokinetics of rosuvastatin, atorvastatin and simvastatin acid in Caucasian and Asian subjects: a class effect?

Authors:  Bruce K Birmingham; Sarah R Bujac; Robert Elsby; Connie T Azumaya; Cheryl Wei; Yusong Chen; Rogelio Mosqueda-Garcia; Helen J Ambrose
Journal:  Eur J Clin Pharmacol       Date:  2015-02-12       Impact factor: 2.953

3.  Rosuvastatin pharmacokinetics and pharmacogenetics in Caucasian and Asian subjects residing in the United States.

Authors:  Bruce K Birmingham; Sarah R Bujac; Robert Elsby; Connie T Azumaya; Julie Zalikowski; Yusong Chen; Kenneth Kim; Helen J Ambrose
Journal:  Eur J Clin Pharmacol       Date:  2015-01-30       Impact factor: 2.953

4.  Development of a model for prediction of coronary atherosclerotic regression: evaluation of high-density lipoprotein cholesterol level and peripheral blood monocyte count.

Authors:  Shigemasa Tani; Michiaki Matsumoto; Takeo Anazawa; Hirofumi Kawamata; Shingo Furuya; Hiroshi Takahashi; Kiyoshi Iida; Takehiko Washio; Narimichi Kumabe; Masashi Kobori; Ken Nagao; Atsushi Hirayama
Journal:  Heart Vessels       Date:  2011-03-18       Impact factor: 2.037

Review 5.  Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin.

Authors:  Pertti J Neuvonen; Janne T Backman; Mikko Niemi
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

6.  Characterization of Statin Low-Density Lipoprotein Cholesterol Dose-Response Using Electronic Health Records in a Large Population-Based Cohort.

Authors:  Akinyemi Oni-Orisan; Thomas J Hoffmann; Dilrini Ranatunga; Marisa W Medina; Eric Jorgenson; Catherine Schaefer; Ronald M Krauss; Carlos Iribarren; Neil Risch
Journal:  Circ Genom Precis Med       Date:  2018-09

Review 7.  The difference between Asian and Western in the effect of LDL-C lowering therapy on coronary atherosclerotic plaque: a meta-analysis report.

Authors:  Yu-Feng Li; Quan-Zhou Feng; Wen-Qian Gao; Xiu-Jing Zhang; Ya Huang; Yun-Dai Chen
Journal:  BMC Cardiovasc Disord       Date:  2015-02-14       Impact factor: 2.298

8.  Absence of ethnic differences in the pharmacokinetics of moxifloxacin, simvastatin, and meloxicam among three East Asian populations and Caucasians.

Authors:  Tomoko Hasunuma; Masahiro Tohkin; Nahoko Kaniwa; In-Jin Jang; Cui Yimin; Masaru Kaneko; Yoshiro Saito; Masahiro Takeuchi; Hiroshi Watanabe; Yasushi Yamazoe; Yoshiaki Uyama; Shinichi Kawai
Journal:  Br J Clin Pharmacol       Date:  2016-03-14       Impact factor: 4.335
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.